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Introduction: Reactive lymphoid hyperplasia is a benign nodular lesion characterized by marked proliferation of
non-neoplastic, polyclonal lymphocytes forming follicles. The lesion is found in various organs such as skin, orbit,
lung, gastrointestinal tract, and liver. However, reactive lymphoid hyperplasia in the thyroid gland is extremely rare.
Here, we present an interesting case of reactive lymphoid hyperplasia in the thyroid, which suggests the nature of
the disease.
Case presentation: A 74-year-old Japanese man was referred to our institute because of a growing well-demarcated
irregular-shaped mass in the right lobe of the thyroid. Malignant lymphoma was suspected by cytology, and right
lobectomy was conducted. A final diagnosis of reactive lymphoid hyperplasia was made by the intimate investigation of
the surgical specimen, with evidence of polyclonal and non-neoplastic lymphatic proliferations forming follicles with an
active germinal center. After an initial uneventful postoperative course, our patient developed severe symptoms of
systemic rheumatic arthritis, and alterations in autoimmune reaction, including clinically overt chronic thyroiditis, were
identified.
Conclusions: Our case demonstrated important clinical information on reactive lymphoid hyperplasia of the thyroid, and
suggested the importance of differential diagnosis, and possible close correlation between systemic autoimmune
disorder and the disease.
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Reactive lymphoid hyperplasia (RLH) is a term that has
been used for localized tumor-forming lymphoid hyperpla-
sia in extranodal organs [1]. The etiology is unknown and it
has been called ‘pseudolymphoma’ [2,3] or ‘nodular lymph-
oid hyperplasia’. RLH is a benign nodular lesion, histo-
pathologically characterized by marked proliferation of
non-neoplastic, polyclonal lymphocytes forming follicles
with an active germinal center. The lesion is found in vari-
ous organs such as skin, orbit, lung, gastrointestinal tract,
and liver [4]. Although the relationship between RLH and
chronic thyroiditis and other autoimmune disease have* Correspondence: nonoda@med.osaka-cu.ac.jp
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unless otherwise stated.been discussed [4,5], involvement of this disease in the thy-
roid is extremely rare. We experienced a case of RHL in
the thyroid gland followed by systemic rheumatoid arthritis
that became symptomatic soon after surgery. In this report,
we will discuss the differential diagnosis of RLH of the thy-
roid gland, and the possible association with systemic im-
mune disorders.Case presentation
A 74-year-old Japanese man underwent an ultrasound
examination for the evaluation of cervical atheroscler-
osis during which an incidental thyroid tumor was dis-
covered. He had had a cerebral infarction eight years
previously, which had been treated conservatively with-
out major complication. There were no familial histories
of thyroid disease or immune disorder claimed. Fine-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A representative ultrasonographic image. A well-
demarcated lobular low-echoic lesion with diffuse short linear high-
echoic spots inside in the thyroid was revealed by ultrasonography.
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revealed clusters of many large atypical cells varying in
size, and poorly differentiated thyroid carcinoma was
suspected. He was, then, referred to our institute for
further treatment.
On admission, he did not present with rapid enlargement
of the tumor, dysphagia, hoarseness, or compression symp-
toms. The right lobe of the thyroid was diffusely swollen
with a smooth surface and normal consistency. No local in-
flammatory reaction, such as redness and edema on the
skin or tenderness, was recognized. No cervical lymphaden-
opathy was palpable. There were no abnormal findings in
his blood count, blood chemistry, and thyroid function.
The serum levels of calcitonin, carcinoembrionic antigen,
and thyroglobulin were within the normal limits (Table 1).
An ultrasonographic examination demonstrated swelling of
the right lobe of the thyroid. Several irregular-shaped le-
sions were found in the right lobe with a maximal diameter
of 21mm. Each lesion showed similar appearance; a well-
demarcated lobular low-echoic lesion with diffuse short lin-
ear high-echoic spots inside (Figure 1). A similar irregular-
shaped mass was revealed by contrast-enhanced computed
tomography. No abnormal nodule in the mediastinum or
the lung was found. Several reactive lymph node swellings
were found along with right juglar chain. Repeated FNA re-
vealed normal thyroid follicular cells with abundant lymph-
atic cells in the background. However, there was no
evidence of tumor cells. Right lobectomy was conducted
intending to clarify the pathological diagnosis with the sus-
picions of lymphoma, or poorly differentiated cancer of the
thyroid according to the information of the primary
physician.Table 1 Laboratory data on admission
WBC 7200/μl (4300-8000)*
RBC 487 x104/μl (450-510)
Hemoglobin 15.1 g/dl (12.4-17.2)
Hematocrit 47.1% (38-54)
Platelet count 20.4 x104/μl (18-34)
Total protein 7.1 g/dl (6.5-8.5)
Albumine 4.2 g/dl (3.5-5.0)
AST 21 IU/l (13-33)
ALT 15 IU/l (8-42)
Total-Bililubin 0.8 mg/dl (0.2-1.0)
Alkaline phosphatase 210 IU/l (115-359)
LDH 177 IU/l (119-229)
Creatine kinase 97 IU/l (30-200)
Glucose 100 mg/dl (70-105)
Total-Cholesterol 232 mg/dl (130-220)
*Reference range; WBC: white blood cell count; RBC: red blood cell count; AST: aspa
dehydrogenase; BUN: blood urea nitrogen; T3: triiodothyronin; T4: thyroxine; TSH th
cell carcinoma antigen.During the operation, the lesion could not be found on
the surface of the thyroid. Several small lymph nodes
around the right lobe were recognized. On the cut surface,
the tumor was lobular and milky white in color, irregularly
but clearly demarcated from the surrounding thyroid gland
(Figure 2). A frozen section demonstrated marked lymph-
oid proliferation suggestive of lymphoma. However, immu-
nostaining for a correct final diagnosis was advised. A
pathological investigation of the operative specimen re-
vealed several nodular tumors, leaving normal thyroidBUN 21.0 mg/dl (7-18)
Creatinine 0.88 mg/dl (05-1.1)
Sodium+ 142 mEq/l (137-146)
Potassium+ 4.7 mEq/l (3.8-5.1)
Chlorine- 108 mEq/l (98-108)
Free T3 3.52 pg/ml (1.71-3.71)
Free T4 1.21 ng/dl (0.70-1.48)
TSH 2.37 μIU/ml (0.35-4.94)
Calcium 9.8 mg/dl (7.0-10.0)
Phosphorus 3.7 mg/dl (2.9-4.3)
Thyroglobulin <5.0 ng/ml (0-30)
Calcitonin 33.0 pg/ml (5-86)
CEA 4.2 ng/ml (0-5.0)
SCC 0.8 ng/ml (0-1.5)
rate aminotransferase; ALT: alanine aminotransferase; LDH: lactate
yroid stimulating hormone; CEA: carcino embryonic antigen; SCC: squamous
Figure 2 The macroscopic cross-sectioned view of the surgical
specimen. A well-demarcated, milky-white mass was found in
the thyroid.
Figure 3 The microscopic view of the specimen. Pathologically,
marked lymphatic infiltrations were found forming various nodules
of lymphatic proliferations (a: hematoxylin and eosin stain x40). A
mixture of small and large lymphocytes with irregular nuclear
borders was shown on high-power field (b: hematoxylin and eosin
stain x200).
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were found within the thyroid gland forming various nod-
ules of lymphatic proliferations. A mixture of small and
large lymphocytes with irregular nuclear borders was
shown on high-power field. Tingible body macrophage, or
mitosis were also recognized. There was no tendency for
differentiation to the plasma cell, or no site to show the
lymphoepithelial lesion (Figure 3). On immunohistochemi-
cal study, both the lymph follicle and the mantle zone were
positive for B-cell marker (CD-20: Figure 4a). A diffuse
positive nuclear stain of cells within the follicle was shown
for follicular origin B-cell marker (bcl-6, CD-10: Figure 4b),
but no cells between follicles showed a positive stain for
these markers. Various degrees of T-cell marker (CD-3)-
positive cell infiltration was found within or around the fol-
licles (Figure 4c). Bcl-2-positive cells were found only at the
marginal zone of the follicle. No bcl-2-positive B cell was
found in the germ center (Figure 4d). Dendric cells within
the follicle were stained positively by follicular-dendric cell
marker (CD-35), and demonstrated the preservation of a
dense network-like appearance (Figure 4e). Positive reactiv-
ity for both κ and λ light chain immunoglobulin (Ig) was
found by in situ hybridization (Figure 4f, g, h). Further-
more, multiplex polymerase chain reaction (PCR) analysis
showed no rearrangement of IgH, indicating polyclonal
proliferation of the lymphoid cells (data not shown). A final
diagnosis of reactive lymphoid hyperplasia of the thyroid
was made according to these pathological findings.
There was no particular event during the initial period
of the postoperative course. No abnormal accumulation
was found by whole-body Ga schintigraphy. Twomonths after the operation, our patient began to feel fin-
ger stiffness and knee pain. Progressive hypothyroidism
became obvious with edema in his lower extremities,
and 50μg of levothyroxine was supplemented, but his
arthralgia progressed. On additional examination, sys-
temic immune disorders as well as autoimmune reaction
to the thyroid gland were demonstrated, and he was re-
vealed to have systemic rheumatic arthritis (Table 2).
Two hundred milligrams of bucillamine was initiated
and his arthralgia relieved within a month. Postoperative
ultrasonography demonstrated diffuse decrease in echo-
genesity without any tumorous lesion in the residual left
lobe of the thyroid gland. Additional impairment of thy-
roid function was noted. These were consistent with the
typical findings of chronic autoimmune thyroiditis. He is
well without severe symptoms at 36 months from sur-
gery, with the administration of 100μg of levothyroxine,
and 200mg of bucillamine.
Discussion
Saltzstein has defined RLH as propagation of lymph follicles
constructed with lymphoid cells without cytological atypia,
Figure 4 Representative images of the immunohistochemical
study. B-cell marker (CD-20: a), follicular origin B-cell marker (CD-10: b),
T-cell marker (CD-3: c), apoptotic marker (Bcl-2: d), follicular-dendric cell
marker (CD-35: e). Universal reactivity for light chain immunoglobulin
were detected by in situ hybridization (hematoxylin and eosin stain:
f, κ: g, and λ: h).
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[6]. Katayanagi also proposed RLH as a localized lesion
well-demarcated from the surrounding tissues and charac-
terized by the presence of hyperplastic lymphoid follicles
with polymorphic and polyclonal cell populations com-
posed of small mature lymphocytes, mature plasma cells,
macropages and stomal fibrosis [7]. Our case wasTable 2 Additional laboratory data*
Free T3 2.23 pg/ml (1.71-3.71)**
Free T4 1.43 ng/dl (0.70-1.48)
TSH 10.1 μIU/ml (0.35-4.94)
CRP 2.39 mg/dl (0-0.4)
Thyroid test# 6400 fold (<100)
Microsome test## 25,600 fold (<100)
Thyroglobulin 5.3 ng/ml (0-30)
*Data taken three months after the operation with the supplementation of levothyr
##semi-quantitative test for anti-thyroid microsomal antibody; $agglutination reactio
T4: thyroxine; TSH thyroid stimulating hormone; CRP: C-reactive protein; RAPA: rheu
complement activity.consistent with these descriptions. As described previously,
reports of cases with RLH of the thyroid are extremely rare
[2,3]. Clinical and pathological manifestations of thyroid
disease with lymphoid infiltrates, such as malignant
lymphoma, Graves’ disease, Hashimoto’s thyroiditis, or de
Quervain’s subacute thyroiditis, have been well established.
Still, typical clinical features of RLH of the thyroid gland
have not been described yet. Thus, the differential diagno-
ses clinically with thyroid tumor or goiter, and pathologic-
ally with malignant lymphoma are mandatory.
Franssila [1] clearly demonstrated several important
points for accurate differential diagnosis. Our case
had no clinical features of hyperthyroidism suggesting
Graves’ disease, or no inflammatory reaction suggesting
acute to subacute thyroiditis. At the time of surgery,
there was no symptom suggesting hypothyroidism. The
thyroid nodule was found only in the right lobe, and dif-
fuse change of the thyroid gland was not recognized.
These findings indicated the absence of typical auto-
immune thyroid disease.
Primary lymphomas represent 1 to 5 percent of thyroid
tumors. Most cases occur in patients who have chronic thy-
roiditis, and there is a distinct female predominance [8].
Pathologically, most thyroid lymphomas are of non-
Hodgkin’s B-cell origin [9]. In the present case, differential
diagnosis from malignant lymphoma was critical. However,
follicular malignant lymphoma should be excluded because
of the morphology of the cells, presence of mitosis, or tingi-
ble body macrophage. Moreover, the immunohistochemical
features, such as normally located bcl-2-positive cells only
at the marginal zone, or preserved dense dendric cell net-
work clearly demonstrated the non-tumoral nature of the
lymphoid infiltration, and was enough to rule out malig-
nant lymphoma.
Mucosa-associated lymphoid tissue (MALT) lymphoma
accounts for 28 to 69 percent of the cases of primary thy-
roid lymphomas [9,10]. Typical pathological features of
MALT lymphoma, such as diffuse monoclonal cell infiltra-
tion of centrocyte-like cell or monocytoid B-cell around theRheumatoid factor 167 IU/ml (0-20)
RAPA 640 fold (<40)
CH50 40.4 CH50/ml (28-45)
Anti-Tg antibody 29.5 U/ml (<0.3)
Anti-nuclear antibody negative (-)
LE test$ negative (-)
oxine (50μg); **Reference range; #semi-quantitative test for thyroglobulin;
n to detect anti-dinitrophenol (DNP) antibody; T3: triiodothyronin;
matoid arthritis particle agglutination; CH50: 50% hemolytic
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the present case. Moreover, both κ and λ light chain im-
munoglobulin was found, and no rearrangement of IgH
was demonstrated, indicating polyclonal proliferation of the
lymphoid cells in this case. Therefore, this case did not
demonstrate the pathological features compatible with
MALT lymphoma.
Focal lymphocytic thyroiditis is a common disorder
[11,12]. Focal nodules of thyroiditis have a wide variety
of appearance. They most commonly appear as solid
hyperechoic nodules with ill-defined margins. However,
there are no sonographic features that can reliably diag-
nose these lesions as thyroiditis and differentiate them
from other lesions [13]. Our case demonstrated well-
bordered focal hypoechoic nodules, and was, therefore,
considered as a tumor rather than a focal lymphatic in-
filtration at the time of the operation. On the other
hand, we could find lymphatic infiltration outside of the
principal lesion, not only pathologically in the operative
specimens but also clinically after the operation. These
findings were suggestive of focal to diffuse lymphocytic
thyroiditis in the thyroid gland, and were not indicative
for lymphoma. The term focal thyroiditis generally sug-
gested a small reversible lesion accompanied with other
main pathological changes. Therefore, we concluded the
lesion in the present case was a RLH of the thyroid.
Most RLH is operated on because of the suspicion of
malignant disease, and the prognosis is reportedly good
[4]. Our case also showed fair prognosis without recur-
rent disease in the thyroid. However, he developed sys-
temic rheumatoid arthritis, and demonstrated clinically
overt progressive autoimmune thyroiditis soon after the
operation. The involvement of systemic autoimmune
disorder in the RLH [4,5], as well as autoimmune thy-
roid disease [14], have been reported. Our case had not
demonstrated any symptoms indicating systemic im-
mune disorder before initial presentation, although he
had been closely followed up for eight years by a local
physician after suffering a cerebral infarction. We could,
thus, suspect that RLH of the thyroid in this case was
initiated as an abnormal local immune reaction caused
by a recently appeared primary systemic autoimmune
disease.
We should have considered the possibility of focal
lymphoid reaction of autoimmune thyroid disease at the
moment of initial presentation. However, lack of the
typical symptoms and data to indicate chronic thyroid-
itis, the relatively acute onset of the disease, and the
cytological suspicion of the malignant disease lead us to
conduct a surgical approach in the present case. Al-
though there remained many points to clarify, our case
demonstrated important clinical information of RLH of
the thyroid, and suggested possible correlation between
systemic autoimmune disorder and the disease.Conclusion
We reported a case of reactive lymphoid hyperplasia of
the thyroid. Our case demonstrated important clinical
information on this rare disease, and suggested the im-
portance of differential diagnosis, and possible close cor-
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